Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

The International Dupuytren Award 2021 for Basic Research was shared between two researchers from the Kennedy Institute of Rheumatology at NDORMS. Lynn Williams was recognised for her paper "Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300" published in PNAS, and Thomas Layton for "Cellular census of human fibrosis defines functionally distinct stromal cell types and states" which appeared in Nature Communications.

The award for Best Clinical Paper award was won by Osaid Alser for the work he completed as MSc by Research student at NDORMS before graduating and moving to Harvard. His paper "Serious complications and risk of re-operation after Dupuytren’s disease surgery: a population-based cohort study of 121,488 patients in England" appeared in Nature Scientific Reports.

Dominic Furniss, who co-supervised Osaid and Thomas, said: “My congratulations go to our researchers who have been recognised for their work by the International Dupuytren Society. The research explores the underlying causes of Dupuyren’s disease and helps us move towards improving treatment for this disabling condition.”

The International Dupuytren Award recognises exceptional scientific publications on research or clinical treatment of Dupuytren and/or Ledderhose disease. 

Similar stories

Dr Kate Coldwell awarded Daphne Jackson Fellowship to study links between liver disease and gut bacteria

Dr Kate Coldwell has joined the Oxford Centre for Microbiome Studies at the Kennedy Institute to study the links between liver disease and gut bacteria, having been awarded the Daphne Jackson Fellowship, co-funded by the Kennedy Trust for Rheumatology Research (KTRR) and the Medical Research Council.